Nature Review Details MASH Pathogenesis Mechanisms

A comprehensive review published online in Nature on September 2, 2026, delves into the intricate molecular and cellular mechanisms that underpin the pathogenesis of metabolic dysfunction-associated steatohepatitis (MASH) and its potential progression to hepatocellular carcinoma (HCC). The review, identified by the digital object identifier 10.1038/s41586-026-10529-0, synthesizes the current state of scientific understanding regarding the complex biological processes involved in MASH development and its adverse outcomes. MASH is a severe form of non-alcoholic fatty liver disease (NAFLD) characterized by liver inflammation and cellular damage, which can lead to fibrosis, cirrhosis, and liver cancer. The review emphasizes the multifaceted nature of MASH pathogenesis, highlighting the interplay of genetic, environmental, and metabolic factors. It explores how metabolic derangements, such as insulin resistance, dyslipidemia, and obesity, contribute to the accumulation of fat in the liver, triggering inflammatory responses and oxidative stress. These cellular insults, in turn, activate signaling pathways that promote fibrogenesis, the excessive deposition of scar tissue in the liver. The review further examines the cellular players involved, including hepatocytes, Kupffer cells (resident liver macrophages), hepatic stellate cells, and endothelial cells, detailing their roles in initiating and perpetuating the inflammatory cascade and fibrotic process. Specific molecular pathways and mediators, such as cytokines, chemokines, growth factors, and reactive oxygen species, are discussed in relation to their contribution to disease progression. The transition from MASH to HCC is a critical concern, and the review dedicates significant attention to the molecular events that drive this oncogenic transformation. It investigates how chronic inflammation, cellular injury, and altered metabolic states create a microenvironment conducive to the development of liver tumors. Mechanisms such as DNA damage, epigenetic alterations, and dysregulation of key signaling pathways involved in cell proliferation, survival, and angiogenesis are explored. The publication in Nature, a leading peer-reviewed scientific journal, signifies the importance and rigor of the research presented, offering a valuable resource for researchers, clinicians, and pharmaceutical developers working to understand and treat MASH and its complications. The review aims to provide a foundational understanding that can guide the development of novel therapeutic strategies targeting specific molecular pathways to prevent or reverse MASH and reduce the incidence of HCC.